iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionMercer Global Advisors Inc /adv
Latest Disclosed Ownership13,732 shares
Latest Disclosed Value $ 2,318,644
Mercer Global Advisors Inc /adv reports 7.39% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 15, 2026 - Mercer Global Advisors Inc /adv filed a 13F-HR form disclosing ownership of 13,732 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $2,318,644 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 12,787 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 7.39% during the quarter. The current value of the position is $1,799,579 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 13,732 945 7.39 2,319 7.46 0.0034
2026-02-17 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 12,787 -274 -2.10 2,158 14.43 0.0033
2025-11-14 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 13,061 -1,715 -11.61 1,886 0.86 0.0031
2025-08-14 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 14,776 -1,333 -8.27 1,869 -9.27 0.0038
2025-05-15 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 16,109 446 2.85 2,060 -0.48 0.0047
2025-02-14 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 15,663 1,605 11.42 2,071 1.72 0.0051
2024-11-14 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 14,058 602 4.47 2,035 10.18 0.0048
2024-08-12 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 13,456 -402 -2.90 1,847 184,600.00 0.0050
2024-05-15 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 13,858 216 1.58 2 0.00 0.0054
2024-02-15 2023-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 13,642 -1,313 -8.78 2 0.00 0.0056
2023-11-15 2023-09-30 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 14,955 -443 -2.88 2 0.00 0.0069
2023-11-14 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 14,955 -443 2 0.0069
2023-08-14 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 15,398 -1,471 -8.72 2 -50.00 0.0078
2023-05-16 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 16,869 102 0.61 2 0.00 0.0099
2023-02-09 2022-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 16,767 5,906 54.38 2 -99.84 0.0110
2022-11-15 2022-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 10,861 2,789 34.55 1,270 33.68 0.0075
2022-08-10 2022-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 8,072 -775 -8.76 950 -17.61 0.0058
2022-05-10 2022-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 8,847 1,511 20.60 1,153 2.95 0.0068
2022-02-04 2021-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 7,336 569 8.41 1,120 2.38 0.0069
2021-11-10 2021-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 6,767 2,968 78.13 1,094 75.88 0.0076
2021-08-10 2021-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,799 982 34.86 622 46.70 0.0048
2021-08-10 2021-03-31 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 2,817 1,176 71.66 424 70.28 0.0039
2021-05-11 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,520 879 379 0.0036
2021-02-12 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,641 -710 -30.20 249 -21.70 0.0031
2020-12-10 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,351 -620 -20.87 318 -21.67 0.0048
2020-08-10 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,971 342 13.01 406 43.46 0.0074
2020-05-18 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,629 -439 -14.31 283 -23.51 0.0062
2020-02-13 2019-12-31 13F ISHARES TR NASDAQ BIOTECH COM 464287556 3,068 -291 -8.66 370 10.78 0.0074
2019-11-12 2019-09-30 13F ISHARES TR NASDAQ BIOTECH COM 464287556 3,359 561 20.05 334 9.51 0.0079
2019-08-14 2019-06-30 13F ISHARES TR NASDAQ BIOTECH COM 464287556 2,798 489 21.18 305 18.22 0.0081
2019-04-23 2019-03-31 13F/A-1 ISHARES TR NASDAQ BIOTECH COM 464287556 2,309 2,309 258 0.0093
2019-04-12 2019-03-31 13F ISHARES TR NASDAQ BIOTEC COM 464287556 2,999 289 0.0154
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.